Reuters Pharma USA 2024: What are key pharma players hoping to achieve?
This week, the pharma industry will descend on Pennsylvania Convention Center for Reuters Pharma USA, North America’s largest cross-functional pharma gathering.
Archives for March 25, 2024
New wave of potential therapies to bring ‘paradigm shift’ in COPD treatment
The recent submission of clinical trial data for Sanofi/Regeneron’s Dupixent and Verona’s Ensifentrine to the U.S. FDA indicates the entry of new therapies for chronic obstructive pulmonary disease (COPD) in 2024.